Skip to main content
. 2016 Winter;15(Suppl):101–112.

Figure 5.

Figure 5

Effect of SVT and Cisplatin on LDH leakage in HepG2 cells. The cells were treated with different concentrations of SVT and Cisplatin for 24 h. At the end of the incubation period, the LDH assay was performed to assess the LDH leakage as described in methods section. No significant difference was observed in LDH leakage at 10 µg/mL of SVT and cisplatine (P<0.05). The data are expressed as mean±SD of three independent experiments